Silverleafe Capital Partners, LLC Johnson & Johnson Transaction History

Silverleafe Capital Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 04, 2023	BUY	$160.2 - $179.79 $193,201 - $216,826	1,206 New	1,206 $0
Q3 2022 Oct 11, 2022	SELL	$161.33 - $179.52 $193,757 - $215,603	-1,201 Closed	0 $0
Q2 2022 Jul 01, 2022	BUY	$168.19 - $186.01 $504 - $558	3 Added 0.25%	1,201 $213,000
Q1 2022 Apr 05, 2022	SELL	$158.14 - $179.59 $2,530 - $2,873	-16 Reduced 1.32%	1,198 $212,000
Q4 2021 Jan 04, 2022	SELL	$155.93 - $173.01 $85,917 - $95,328	-551 Reduced 31.22%	1,214 $208,000
Q3 2021 Oct 13, 2021	SELL	$161.5 - $179.47 $79,458 - $88,299	-492 Reduced 21.8%	1,765 $285,000
Q1 2021 Apr 07, 2021	BUY	$153.07 - $170.48 $345,478 - $384,773	2,257 New	2,257 $371,000
Q2 2019 Jul 03, 2019	SELL	$131.15 - $144.24 $303,481 - $333,771	-2,314 Closed	0 $0
Q1 2019 Apr 10, 2019	BUY	$125.72 - $139.79 $251 - $279	2 Added 0.09%	2,314 $323,000
Q4 2018 Jan 04, 2019	BUY	$122.84 - $147.84 $284,006 - $341,806	2,312 New	2,312 $298,000

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Silverleafe Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverleafe Capital Partners, LLC with notifications on news.